Two separate things go wrong at once. The first is a blind spot: a clean mammogram catches roughly 87% of cancers in fatty breasts but only about 65% in the densest, because the tumor hides against white tissue ¹. The second is real risk: women with the densest tissue get breast cancer four to five times as often as women with the least dense ². Both are settled. The group screening catches least is the same group that gets cancer most.

The cancers screening misses still arrive. They turn up in the gap between scans, felt as a lump rather than caught on film, and those run larger and do worse. In extremely dense breasts about half of cancers show up this way ³. Adding an MRI in that group cut the interval-cancer rate in half ³.

Your job is one clinic conversation. Walk in with the density line from your report and these three asks.

The three options, plainly. Ultrasound adds about four cancers per 1000 screens, needs no contrast or radiation, and is the fallback when the others are ruled out ⁵. MRI has the highest sensitivity and is what halved interval cancers in the trial ³. Contrast mammography matches MRI in dense breasts at lower cost and shorter time ⁶.

What acting buys you is what doesn't happen. A clean supplemental scan makes the negative real instead of hopeful, and the year ahead is quieter for it. If something turns up, it is far likelier to be small and treatable with a lumpectomy than a lump you find yourself years later. The trial behind this measured fewer interval cancers rather than fewer deaths, so the survival gain is inferred and still unproven ³.

Cost is a lottery: about half of US states mandate no-copay coverage, and elsewhere MRI runs roughly $400 to $2,000 out of pocket. The USPSTF still calls the supplemental-imaging evidence insufficient, so this is a shared decision rather than a settled order ⁷.